Diabetes is a lifelong metabolic condition in which the body does not produce sufficient insulin to regulate blood glucose levels.
Diabetes can lead to several long-term complications that affect blood vessels and circulation. People with diabetes are at significantly greater risk than the general population of developing other conditions such as:
The cardiovascular disease profiles are available for commissioners and health professionals when assessing the impact of cardiovascular diseases, such as these on their local population and making decisions about services.
An auto-immune condition in which the cells that produce insulin are destroyed. It requires lifelong treatment with insulin to prevent further complications.
Around 8% of people with diabetes have Type 1 diabetes.
It occurs when the body stops producing enough insulin for its needs and is usually accompanied by resistance to the effect of insulin.
The condition is progressive requiring lifestyle management at all stages, including diet and exercise. At some point, a person with Type 2 diabetes may need medication and possibly insulin.
Type 2 diabetes accounts for around 90% of people with diabetes.
People with diabetes are at greater risk of foot disease due to vascular damage impairing the circulation in the feet. Cuts and sores are therefore less likely to be identified by patients, potentially leading to infection, ulceration, amputation or even death.
The NCVIN produces diabetes foot care indicators for each Integrated Care Boards in England. These indicators are a measure of the effectiveness of health care and the foot care system for patients with diabetes in an area. They are based on data taken from:
Access a spreadsheet containing the latest update for these indicators. An accompanying technical document is also available.
Last update of these statistics is from January 2023.
Note: There is a scheduled refresh of the amputation indicators available on this profile (Indicator IDs: 93047 and 93049) in a future update. The source of the indicators will change from the current data source to the same data source which is used for the National Diabetes Audit Complications and Mortality data . There will be no change to the methodology used to calculate the indicators which controls for differences in age and ethnicity among the local diabetes population. This change will lead to a complete revision of the data for all areas. New backdated data and trends will be made available upon release.
For more information, users of these indicators are welcome to contact the indicator producers at: ncvin-ohid@dhsc.gov.uk
